Boston Scientific Corporation (BIT:1BSX)

Market Cap	64.88B -50.0%
Revenue (ttm)	18.38B +13.5%
Net Income	3.22B +46.7%
EPS	2.16 +46.9%
Shares Out	n/a
PE Ratio	20.17
Forward PE	15.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,073
Open	45.92
Previous Close	44.78
Day's Range	45.21 - 46.51
52-Week Range	37.00 - 92.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatogra...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1979
• Employees: 59,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1BSX

Financial Performance

In 2025, Boston Scientific's revenue was $20.07 billion, an increase of 19.87% compared to the previous year's $16.75 billion. Earnings were $2.90 billion, an increase of 56.40%.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 17, 2026

Data Sources Report a data error